These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34790230)

  • 1. Association Between
    Zheng K; Yao S; Yao W; Li Q; Wang Y; Zhang L; Chen X; Xiong H; Yuan X; Wang Y; Zou Y; Xiong H
    Front Genet; 2021; 12():770134. PubMed ID: 34790230
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between FGFR2 and RSK2-implications for breast cancer prognosis.
    Czaplinska D; Mieczkowski K; Supernat A; Skladanowski AC; Kordek R; Biernat W; Zaczek AJ; Romanska HM; Sadej R
    Tumour Biol; 2016 Oct; 37(10):13721-13731. PubMed ID: 27476168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of submucosal tunneling endoscopic resection for gastric submucosal tumors: a systematic review and meta-analysis.
    Cao B; Lu J; Tan Y; Liu D
    Rev Esp Enferm Dig; 2021 Jan; 113(1):52-59. PubMed ID: 33222480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mTOR inhibitors, a new era for metastatic luminal HER2-negative breast cancer? A systematic review and a meta-analysis of randomized trials.
    Rotundo MS; Galeano T; Tassone P; Tagliaferri P
    Oncotarget; 2016 May; 7(19):27055-66. PubMed ID: 26895472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Theragnostic Relationship between Drug-Resistance Specific miRNA Expressions, Chemotherapeutic Resistance, and Sensitivity in Breast Cancer: A Systematic Review and Meta-Analysis.
    Jayaraj R; Nayagam SG; Kar A; Sathyakumar S; Mohammed H; Smiti M; Sabarimurugan S; Kumarasamy C; Priyadharshini T; Gothandam KM; Ramesh N; Gupta A; Baxi S; Swamiappan S; Krishnan S
    Cells; 2019 Oct; 8(10):. PubMed ID: 31615089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of and risk factors for Plasmodium spp. co-infection with hepatitis B virus: a systematic review and meta-analysis.
    Kotepui KU; Kotepui M
    Malar J; 2020 Oct; 19(1):368. PubMed ID: 33059662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive and prognostic role of tumour-infiltrating lymphocytes in breast cancer patients with different molecular subtypes: a meta-analysis.
    Gao ZH; Li CX; Liu M; Jiang JY
    BMC Cancer; 2020 Nov; 20(1):1150. PubMed ID: 33238978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simplification and implementation of random-effects meta-analyses based on the exact distribution of Cochran's Q.
    Preuß M; Ziegler A
    Methods Inf Med; 2014; 53(1):54-61. PubMed ID: 24317521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Akt regulates RSK2 to alter phosphorylation level of H2A.X in breast cancer.
    Guo ZF; Kong FL
    Oncol Lett; 2021 Mar; 21(3):187. PubMed ID: 33574926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The p90 ribosomal S6 kinase 2 specifically affects mitotic progression by regulating the basal level, distribution and stability of mitotic spindles.
    Park YY; Nam HJ; Do M; Lee JH
    Exp Mol Med; 2016 Aug; 48(8):e250. PubMed ID: 27491410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RSK1 and RSK2 serine/threonine kinases regulate different transcription programs in cancer.
    Yang WS; Caliva MJ; Khadka VS; Tiirikainen M; Matter ML; Deng Y; Ramos JW
    Front Cell Dev Biol; 2022; 10():1015665. PubMed ID: 36684450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RSK2 signals through stathmin to promote microtubule dynamics and tumor metastasis.
    Alesi GN; Jin L; Li D; Magliocca KR; Kang Y; Chen ZG; Shin DM; Khuri FR; Kang S
    Oncogene; 2016 Oct; 35(41):5412-5421. PubMed ID: 27041561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of RSK2 influences the biological activities of human osteosarcoma cells through inactivating AKT/mTOR signaling pathways.
    Qiu Q; Jiang J; Lin L; Cheng S; Xin D; Jiang W; Shen J; Hu Z
    Int J Oncol; 2016 Jun; 48(6):2508-20. PubMed ID: 27082640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profile of SIX family members correlates with clinic-pathological features and prognosis of breast cancer: A systematic review and meta-analysis.
    Xu HX; Wu KJ; Tian YJ; Liu Q; Han N; He XL; Yuan X; Wu GS; Wu KM
    Medicine (Baltimore); 2016 Jul; 95(27):e4085. PubMed ID: 27399099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RSK2 protects human breast cancer cells under endoplasmic reticulum stress through activating AMPKα2-mediated autophagy.
    Li LY; Chen XS; Wang KS; Guan YD; Ren XC; Cao DS; Sun XY; Li AX; Tao YG; Zhang Y; Yin MZ; Wang XL; Wu MH; Yang JM; Cheng Y
    Oncogene; 2020 Oct; 39(43):6704-6718. PubMed ID: 32958832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological grade provides significant prognostic information in addition to breast cancer subtypes defined according to St Gallen 2013.
    Ehinger A; Malmström P; Bendahl PO; Elston CW; Falck AK; Forsare C; Grabau D; Rydén L; Stål O; Fernö M;
    Acta Oncol; 2017 Jan; 56(1):68-74. PubMed ID: 27762648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer.
    Heimes AS; Madjar K; Edlund K; Battista MJ; Almstedt K; Gebhard S; Foersch S; Rahnenführer J; Brenner W; Hasenburg A; Hengstler JG; Schmidt M
    J Cancer Res Clin Oncol; 2017 Jul; 143(7):1123-1131. PubMed ID: 28251349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal body mass index and risk of testicular cancer in male offspring: a systematic review and meta-analysis.
    Alam SS; Cantwell MM; Cardwell CR; Cook MB; Murray LJ
    Cancer Epidemiol; 2010 Oct; 34(5):509-15. PubMed ID: 20800565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IMP1 promotes choriocarcinoma cell migration and invasion through the novel effectors RSK2 and PPME1.
    Hsieh YT; Chou MM; Chen HC; Tseng JJ
    Gynecol Oncol; 2013 Oct; 131(1):182-90. PubMed ID: 23911878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.